Nikola Valkov
- Co-authors
- Daniel M. SullivanJana GumpEdward SetoShih‐Chang TsaiWen‐Ming YangLori HazlehurstDavid BoulwareWilliam S. Dalton
- Topics
- Cancer therapeutics and mechanisms (10 papers)Cancer Research and Treatments (3 papers)Cancer-related Molecular Pathways (3 papers)
- Partner nations
- United StatesBulgariaUnited Kingdom
In The Last Decade
Nikola Valkov
19 papers receiving 604 citations
Peers
Comparison fields: 5 of 75
- Molecular Biology 369
- Oncology 161
- Hematology 63
- Plant Science 63
- Cancer Research 58
Countries citing papers authored by Nikola Valkov
This map shows the geographic impact of Nikola Valkov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikola Valkov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikola Valkov more than expected).
Fields of papers citing papers by Nikola Valkov
This network shows the impact of papers produced by Nikola Valkov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikola Valkov. The network helps show where Nikola Valkov may publish in the future.
Co-authorship network of co-authors of Nikola Valkov
This figure shows the co-authorship network connecting the top 25 collaborators of Nikola Valkov. A scholar is included among the top collaborators of Nikola Valkov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nikola Valkov. Nikola Valkov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | 11 | |
| 3 | 25 | |
| 4 | Is cytoplasmic localization of topoisomerase I (topo I) a mechanism of resistance for topo I inhibitors? Results from an NCCN sponsored phase II trial of gemcitabine and irinotecan in metastatic breast cancer. | 1 |
| 5 | 2 | |
| 6 | 57 | |
| 7 | 30 | |
| 8 | 28 | |
| 9 | 105 | |
| 10 | 31 | |
| 11 | 133 | |
| 12 | 53 | |
| 13 | 2 | |
| 14 | Prolonged activation of the mitogen-activated protein kinase pathway is required for macrophage-like differentiation of a human myeloid leukemic cell line. | 51 |
| 15 | 25 | |
| 16 | 4 | |
| 17 | 17 | |
| 18 | 14 | |
| 19 | Electron microscopic demonstration of transcription of ram sperm chromatin. | 8 |
| 20 | Electron microscopic data for the presence of post-meiotic gene expression in isolated ram sperm chromatin. | 8 |
About Nikola Valkov
Nikola Valkov is a scholar working on Biotechnology, Parasitology and Oncology, having authored 20 papers that have together received 623 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (10 papers), Cancer Research and Treatments (3 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Immunology and Allergy (41 citations), Endocrinology (31 citations) and Oncology (161 citations). Nikola Valkov has collaborated with scholars based in United States, Bulgaria and United Kingdom. Frequent co-authors include Daniel M. Sullivan, Jana Gump, Edward Seto, Shih‐Chang Tsai, Wen‐Ming Yang, Lori Hazlehurst, David Boulware, William S. Dalton, Lee Wisner and Burt Anderson. Their work appears in journals such as Nature Genetics, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.